Jovan P. Antović

1.7k total citations
81 papers, 1.2k citations indexed

About

Jovan P. Antović is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, Jovan P. Antović has authored 81 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Hematology, 32 papers in Cardiology and Cardiovascular Medicine and 22 papers in Internal Medicine. Recurrent topics in Jovan P. Antović's work include Blood Coagulation and Thrombosis Mechanisms (28 papers), Venous Thromboembolism Diagnosis and Management (22 papers) and Atrial Fibrillation Management and Outcomes (21 papers). Jovan P. Antović is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (28 papers), Venous Thromboembolism Diagnosis and Management (22 papers) and Atrial Fibrillation Management and Outcomes (21 papers). Jovan P. Antović collaborates with scholars based in Sweden, Serbia and Slovenia. Jovan P. Antović's co-authors include Rickard E. Malmström, Aleksandra Antovič, Anton Pohanka, Håkan Wallén, Margareta Blombäck, Mika Skeppholm, Gun Jörneskog, Fariborz Mobarrez, Yuko Rönquist-Nii and Nils Egberg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jovan P. Antović

72 papers receiving 1.2k citations

Peers

Jovan P. Antović

CCM

HEMAT

SURGE

Ján Staško Slovakia

Dimitrios A. Tsakiris Switzerland

Peter Kubisz Slovakia

Dominique Lasne France

Gian Marco Podda Italy

Anna‐Marie Bloch Münster Denmark

Margareta Sten-Linder Sweden

Kathleen E. Brummel United States

François Depasse France

Argyri Gialeraki Greece

Ján Staško Slovakia

Jovan P. Antović

488 ×1.0

CCM

471 ×1.2

HEMAT

339 ×1.0

73 ×0.4

199 ×1.6

SURGE

Citations per year, relative to Jovan P. Antović Jovan P. Antović (= 1×) peers Ján Staško

Countries citing papers authored by Jovan P. Antović

Since Specialization

Citations

This map shows the geographic impact of Jovan P. Antović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jovan P. Antović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jovan P. Antović more than expected).

Fields of papers citing papers by Jovan P. Antović

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jovan P. Antović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jovan P. Antović. The network helps show where Jovan P. Antović may publish in the future.

Co-authorship network of co-authors of Jovan P. Antović

This figure shows the co-authorship network connecting the top 25 collaborators of Jovan P. Antović. A scholar is included among the top collaborators of Jovan P. Antović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jovan P. Antović. Jovan P. Antović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mijovski, Mojca Božič, Alenka Mavri, Jovan P. Antović, Rickard E. Malmström, & Désirée Coen Herak. (2025). Multicenter Evaluation of Different Anti-Xa Assays and Diluted Russell’s Viper Venom Time in Ex Vivo Plasma Samples from Patients Treated with Rivaroxaban or Apixaban. Journal of Clinical Medicine. 14(23). 8274–8274.

Taxiarchis, Apostolos, et al.. (2025). High complement expression on extracellular vesicles in Covid-19 patients without pulmonary embolism leading to death. Case report. Immunology Letters. 277. 107104–107104.

Reitzner, Stefan Markus, Aisha Ahmed, Li Guo, et al.. (2025). The acute effects of neuromuscular electrical stimulation on coagulation and cardiovascular factors. Physiological Genomics. 57(6). 391–402.

Sjöström, Anna, Jonas Sundén‐Cullberg, Apostolos Taxiarchis, et al.. (2024). Tocilizumab reduces hypercoagulation in COVID-19 – Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial. Thrombosis Research. 243. 109135–109135. 1 indexed citations

Antović, Jovan P., et al.. (2024). The role of complement and extracellular vesicles in the development of pulmonary embolism in severe COVID-19 cases. PLoS ONE. 19(8). e0309112–e0309112. 1 indexed citations

Taxiarchis, Apostolos, Bo‐Michael Bellander, Jovan P. Antović, et al.. (2023). Extracellular vesicles in plasma and cerebrospinal fluid in patients with COVID‐19 and neurological symptoms. International Journal of Laboratory Hematology. 46(1). 42–49. 5 indexed citations

Taxiarchis, Apostolos, et al.. (2023). Effect of prothrombin Belgrade mutation, causing antithrombin resistance, on fibrin clot properties. International Journal of Laboratory Hematology. 46(2). 329–335. 2 indexed citations

Szántó, Tímea, Eva Zetterberg, Sofia Ramström, et al.. (2022). Platelet function testing: Current practice among clinical centres in Northern Europe. Haemophilia. 28(4). 642–648. 7 indexed citations

Sjöström, Anna, Anna Warnqvist, Maria Magnusson, et al.. (2021). Platelet Count Rose While D-Dimer Levels Dropped as Deaths and Thrombosis Declined—An Observational Study on Anticoagulation Shift in COVID-19. Thrombosis and Haemostasis. 121(12). 1610–1621. 14 indexed citations

10.

Siddiqui, Anwar J., et al.. (2018). Age‐adjusted D‐dimer cut‐off leads to more efficient diagnosis of venous thromboembolism in the emergency department: a comparison of four assays. Journal of Thrombosis and Haemostasis. 16(5). 866–875. 24 indexed citations

11.

Antovič, Aleksandra, Maria Berndtsson, Agnes Rasmuson, et al.. (2017). Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting. Thrombosis and Haemostasis. 117(9). 1700–1704. 37 indexed citations

12.

Malmström, Rickard E., Jovan P. Antović, Anton Pohanka, et al.. (2016). Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation. European Journal of Clinical Pharmacology. 72(6). 671–679. 28 indexed citations

13.

Skeppholm, Mika, Paul Hjemdahl, Jovan P. Antović, et al.. (2014). On the monitoring of dabigatran treatment in “real life” patients with atrial fibrillation. Thrombosis Research. 134(4). 783–789. 42 indexed citations

14.

Sonnevi, Kristina, Svetlana Tchaikovski, Margareta Holmström, et al.. (2013). Obesity and thrombin-generation profiles in women with venous thromboembolism. Blood Coagulation & Fibrinolysis. 24(5). 547–553. 21 indexed citations

15.

Renné, Thomas, et al.. (2009). Factor XI deficiency in animal models. Journal of Thrombosis and Haemostasis. 7. 79–83. 48 indexed citations

16.

Obradović, Slobodan, Jovan P. Antović, Nebojša Antonijević, et al.. (2009). Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention. Blood Coagulation & Fibrinolysis. 20(4). 283–289. 17 indexed citations

17.

Antović, Jovan P., Sam Schulman, In Bum Suh, Robert S. Greenfield, & M. Blombäck. (2004). Does an enzyme other than thrombin contribute to unexpected changes in the levels of the different forms of thrombin activatable fibrinolysis inhibitor in patients with hemophilia A, hemophilia B and von Willebrand disease?. Scandinavian Journal of Clinical and Laboratory Investigation. 64(8). 745–752. 6 indexed citations

18.

Antović, Jovan P., Marianne Yngen, Aleksandra Antovič, et al.. (2003). Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications. Blood Coagulation & Fibrinolysis. 14(6). 551–556. 22 indexed citations

19.

Antović, Jovan P. & Margareta Blombäck. (2002). Thrombin-activatable fibrinolysis inhibitor antigen and TAFI activity in patients with APC resistance caused by factor V Leiden mutation. Thrombosis Research. 106(1). 59–62. 10 indexed citations

20.

Antović, Jovan P., et al.. (1993). Blood coagulation factors changes during liver regeneration in rats. Archives Internationales de Physiologie de Biochimie et de Biophysique. 101(6). 357–359. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact